Cansino Biologics Inc.

This early-stage study tests a new tuberculosis (TB) vaccine called Ad5-105K in 36 healthy adults aged 18 to 49 who have a positive TB blood test but no active disease. The main goal is to check the vaccine's safety and how well the body's immune system responds. Participants wil…

This study tests a vaccine that protects against four types of meningococcal bacteria that cause meningitis, a serious brain infection. It involves 660 children aged 6 to 23 months who receive two doses of the vaccine. Researchers check how well the vaccine triggers the immune sy…